Immunity and metabolism
Inflammatory processes, immune-cell function and biological barriers.
University Medicine Magdeburg
Led by: Prof. Dr. med. Johann Steiner
At SASLAB, we investigate how the immune system, metabolism and the brain interact in schizophrenia and mood disorders. Clinical questions guide our research.
Why do illness trajectories differ? Which biological changes accompany an acute episode, and which persist beyond it? What information might support more individualised care in the future? We connect well-characterised patient cohorts with studies of blood, cerebrospinal fluid and brain tissue, alongside imaging and digital methods.
A central focus is biological variation within and across diagnoses. Whether a research finding adds value for individual patients must be established in independent studies.
Research areas
Inflammatory processes, immune-cell function and biological barriers.
Neuronal antibodies, clinical context and differential diagnosis.
NfL, IGFBP2 and other candidates interpreted in their clinical context.
Microglia, tissue organisation and digital neuropathology.
Brevican and molecular findings in serum and CSF.
Psychosis risk, clinical trajectories and the ORAKEL study.
Our new study examines peripheral immune-cell energy metabolism in acute and stably treated schizophrenia.
University Medicine presents our observational study into earlier identification of depressive relapse.
Publications
2026 · Journal article
Peripheral immune-cell bioenergetics in acute and stable schizophrenia
2026 · Review
Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications
2026 · Journal article
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis
2025 · Review
Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis
Projects and care
ORAKEL investigates depressive relapse. Within DZPG, we collaborate on neuroimmune research. FeTZ connects psychosis early detection with clinical support.